// App-Quantinova.ai

: MAJOR OR CLINICALLY RELEVANT NON-MAJOR HEMORRHAGIC EVENTS IN A LARGE POPULATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA: LOCALIZATION, CONSEQUENCES AND DRUG USE

Researchers

Presenter

  • Christophe Nicol

Principal Investigators

  • Brigitte Pan-Petesch

  • Claudie Leostic

  • Gaelle Guillerm

  • Laura Herbreteau

  • Karine Lacut

  • Eric Lippert

  • Jean-Christophe Ianotto

Medical Centers

  • CHU Brest, Brest, France

  • EFS Bretagne,Brest,France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Essential thrombocythemia

  • Polycythemia vera

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • NCT02897297

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved